Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Go back to Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates| (NASDAQ: ELTX) | Delayed: 3.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.98 | 52 Week High | $ | |||
| Open | $3.98 | 52 Week Low | $ | |||
| Day High | $3.98 | P/E | N/A | |||
| Day Low | $3.98 | EPS | $ | |||
| Volume | 34,944 | |||||

